Intracerebral hemorrhage risk after adjunct intraarterial thrombolysis in thrombectomy-treated acute ischemic stroke.

Details

Serval ID
serval:BIB_23472E0E2B17
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Intracerebral hemorrhage risk after adjunct intraarterial thrombolysis in thrombectomy-treated acute ischemic stroke.
Journal
Journal of neuroimaging
Author(s)
Qureshi A.I., Huang Y., Bhatti I.A., Gomez C.R., Hanley D.F., Ford D.E., Hassan A.E., Nguyen T.N., Spiotta A.M., Veznedaroglu E., Budzik R.F., Gupta R., Nogueira R.G., Krajina A., Bartolini B., English J., Baxter B., Liebeskind D.S.
ISSN
1552-6569 (Electronic)
ISSN-L
1051-2284
Publication state
Published
Issued date
2024
Peer-reviewed
Oui
Volume
34
Number
6
Pages
773-780
Language
english
Notes
Publication types: Journal Article ; Multicenter Study
Publication Status: ppublish
Abstract
Intraarterial thrombolysis as an adjunct to mechanical thrombectomy is increasingly being considered to enhance reperfusion in acute ischemic stroke patients. Intraarterial thrombolysis may increase the risk of post-thrombectomy intracerebral hemorrhage (ICH) in certain patient subgroups.
We analyzed acute ischemic stroke patients treated with mechanical thrombectomy in a multicenter registry. The occurrence of any (asymptomatic and symptomatic) post-thrombectomy ICH was ascertained using standard definition requiring serial neurological examinations and computed tomographic scans acquired within 48 hours of the thrombectomy. We determined the risk of ICH in subgroups defined by clinical characteristics and the use of intravenous (IV) thrombolysis.
A total of 146 (7.5%) patients received intraarterial thrombolysis among 1953 acute ischemic stroke patients who underwent mechanical thrombectomy. The proportion of patients who developed any ICH was 26 (17.8%) and 510 (28.2%) among patients who were and were not treated with intraarterial thrombolysis, respectively (p = .006). The proportion of patients who developed symptomatic ICH was 4 (2.7%) and 30 (1.7%) among patients who were and were not treated with intraarterial thrombolysis, respectively (p = .34). Among patients who received IV thrombolysis (n = 1042), the proportion of patients who developed any ICH was 9 (16.7%) and 294 (30.7%) among patients who were and were not treated with intraarterial thrombolysis, respectively (p = .028). The risk was not different in strata defined by age, gender, location of occlusion, preprocedure National Institutes of Health Stroke Scale score, time interval between symptom onset and thrombectomy, Alberta Stroke Program Early CT Score, systolic blood pressure, and serum glucose concentrations.
In patients undergoing mechanical thrombectomy, the risk of any ICH and symptomatic ICH was not increased with intraarterial thrombolysis, including in those who had already received IV thrombolytics.
Keywords
Humans, Male, Female, Aged, Thrombolytic Therapy/adverse effects, Cerebral Hemorrhage/diagnostic imaging, Ischemic Stroke/diagnostic imaging, Ischemic Stroke/surgery, Thrombectomy/methods, Fibrinolytic Agents/administration & dosage, Fibrinolytic Agents/adverse effects, Middle Aged, Treatment Outcome, Registries, Combined Modality Therapy, Risk Factors, Aged, 80 and over, intraarterial thrombolysis, intravenous thrombolysis, ischemic stroke, mechanical thrombectomy, multicenter registry
Pubmed
Web of science
Create date
30/09/2024 12:47
Last modification date
19/11/2024 7:22
Usage data